new_0222_0158|KYMR|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0158|KYMR|1|Kymera Therapeutics Inc Total Current Assets (Quarterly) (USD)|Kymera Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Kymera Therapeutics Inc Inventories (Quarterly) (USD)|Kymera Therapeutics Inc Net PP&E (Quarterly) (USD)|Kymera Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Kymera Therapeutics Inc Total Liabilities (Quarterly) (USD)|Kymera Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Kymera Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Kymera Therapeutics Inc Total Deposits (Quarterly) (USD)|Kymera Therapeutics Inc Book Value (Quarterly) (USD)|Kymera Therapeutics Inc Retained Earnings (Quarterly) (USD)|Kymera Therapeutics Inc Treasury Stock (Quarterly) (USD)|Kymera Therapeutics Inc EV to Revenues|Kymera Therapeutics Inc EV to Earnings|Kymera Therapeutics Inc EV to Free Cash Flow|Kymera Therapeutics Inc EV to Assets (Quarterly)|Kymera Therapeutics Inc PS Ratio|Kymera Therapeutics Inc PE Ratio|Kymera Therapeutics Inc Price to Book Value|Kymera Therapeutics Inc PEG Ratio|Kymera Therapeutics Inc Debt to Equity Ratio|Kymera Therapeutics Inc Dividend Yield|Kymera Therapeutics Inc Shareholder Yield (TTM)|Kymera Therapeutics Inc Percent of Shares Outstanding Short|Kymera Therapeutics Inc Total Receivables (Quarterly) (USD)|Kymera Therapeutics Inc Total Payables (Quarterly) (USD)|Kymera Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Kymera Therapeutics Inc Return on Invested Capital|Kymera Therapeutics Inc Quality Ratio Score|Kymera Therapeutics Inc Momentum Score|Kymera Therapeutics Inc Beta (1Y)|Kymera Therapeutics Inc Sustainable Growth Rate (TTM)|Kymera Therapeutics Inc Institutional Investor Ownership Percentage|Kymera Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Kymera Therapeutics Inc Total Employees (Annual)|Kymera Therapeutics Inc EPS Diluted (Quarterly) (USD)|Kymera Therapeutics Inc SG&A Expense (Quarterly) (USD)|Kymera Therapeutics Inc Shares Outstanding|Kymera Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Kymera Therapeutics Inc Ordinary Shares Number (Quarterly)|Kymera Therapeutics Inc Payout Ratio|Kymera Therapeutics Inc Quick Ratio (Quarterly)|Kymera Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Kymera Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Kymera Therapeutics Inc Effective Tax Rate (TTM)|Kymera Therapeutics Inc Return on Equity|Kymera Therapeutics Inc Net Income (TTM) (USD)|Kymera Therapeutics Inc Revenue (TTM) (USD)|Kymera Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Kymera Therapeutics Inc Revenue (Quarterly) (USD)|Kymera Therapeutics Inc Gross Profit (Quarterly) (USD)|Kymera Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Kymera Therapeutics Inc Net Income (Quarterly) (USD)|Kymera Therapeutics Inc Net Interest Income (Quarterly) (USD)|Kymera Therapeutics Inc Price (USD)|Kymera Therapeutics Inc Total Return Price (USD)|Kymera Therapeutics Inc Enterprise Value (USD)|Kymera Therapeutics Inc 30-Day Average Daily Volume|Kymera Therapeutics Inc 1 Year Price Returns (Daily)|Kymera Therapeutics Inc Short Interest|Kymera Therapeutics Inc PE Ratio (Forward)|Kymera Therapeutics Inc PE Ratio (Forward 1y)|Kymera Therapeutics Inc PS Ratio (Forward)|Kymera Therapeutics Inc PS Ratio (Forward 1y)|Kymera Therapeutics Inc Quarterly EPS Estimates (USD)|Kymera Therapeutics Inc Quarterly Revenue Estimates (USD)|Kymera Therapeutics Inc Quarterly EPS Surprise|Kymera Therapeutics Inc Quarterly Revenue Surprise|Kymera Therapeutics Inc Quarterly Actual EPS (USD)|Kymera Therapeutics Inc Quarterly Actual Revenue (USD)|Kymera Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Kymera Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Kymera Therapeutics Inc Price Target (USD)|Kymera Therapeutics Inc Consensus Recommendation|Kymera Therapeutics Inc Price Target Num Estimates|Kymera Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Kymera Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Kymera Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Kymera Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Kymera Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Kymera Therapeutics Inc Land and Improvements (Quarterly) (USD)|Kymera Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Kymera Therapeutics Inc Other Properties (Quarterly) (USD)|Kymera Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0158|KYMR|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0158|KYMR|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0158|KYMR|5|106.5|106.5||106.5||106.5|106.5|106.5||106.5|106.5||1.44827586207|91.25|1.44755244755|91.25|1.44827586207||1.44827586207||91.2857142857|1.44827586207|91.25|15.2352941176|106.5|106.5|106.5|91.25||30.75|30.6|91.25||91.375|91.4|91.375|91.375|31.2857142857||106.5|91.4|91.2857142857|91.375|91.25||91.25|91.4|91.4||91.375||91.375|91.375|91.375|1.44827586207|1.44827586207|1.44827586207|1.44827586207|1.432|15.2352941176|||1.44755244755|1.44755244755|91.3333333333|91.3333333333|91.25|91.25|91.25|91.25|15.0588235294|23.2727272727|16.5161290323|7.64179104478|16.5161290323|16|15.5151515152|91.375|91.375|91.375|||106.5|106.5||
new_0222_0158|KYMR|6|6|6||6||6|6|6||6|6||377|4|286|4|377||377||7|377|4|34|6|6|6|4||4|5|4||8|5|8|8|14||6|5|7|8|4||4|5|5||8||8|8|8|377|377|377|348|125|34|||286|286|9|9|4|4|4|4|34|22|31|67|31|32|33|8|8|8|||6|6||
new_0222_0158|KYMR|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0158|KYMR|201909||||||||||||||||||||||||||||||||||30.1951||-0.3782|1.501||||||-0.3782|||||||0.95||-11.42|-11.42|0.441||||||||||||||||||||||||11.31|0.158|0.004||||||
new_0222_0158|KYMR|201912|92.845|91.957||22.083||191.108|34.57|156.538||-74.406|-76.456|||||||||||||||3.276||||||||30.1951||-0.3813|2.53|||41.7241||2.66|-0.3813|||||||1.833||-11.513|-11.513|0.27||||||||||||||||||||||||11.086|0.361|0.03|||21.959|0.175||
new_0222_0158|KYMR|202003||||||||||||||||||||||||||||||||||30.1951||-0.6618|2.559||||||-0.362|||||||3.428||-10.932|-10.932|0.315||||||||||||||||||||||||12.116|0.387|0.034||||||
new_0222_0158|KYMR|202006|158.301|155.965||20.285||77.066|42.68|34.386||104.043|-108.094||133.122||||111.0819||13.6529|||||0.4413||3.982|0.003|||||||41.7241|55|-0.3353|3.661|44.5295||41.7241||3.6543|-0.3353||||-47.854|9.499||3.288||-13.989|-13.989|0.203|31.9|31.9|1264.526|||196509||||||||||||||||||13.819|0.389|0.025|||14.662|0.175||
new_0222_0158|KYMR|202009|297.364|293.841||20.943||212.676|107.286|105.39||294.685|-116.08||49.4872|-25.7151||2.2514|42.9707||4.8734|||||1.3405|0.577|3.979|0.004|-41.0888||||-41.0888|60.7036|20.6774|64|-0.39|6.838|44.4477||44.4477||2.7442|-0.39|-196.275||-41.0888|-44.42|23.082||14.533||-7.986|-7.986|0.097|32.31|32.31|1142.2642|115242.6667||595836|||||2.91|9|-113.4021|61.4778|-0.39|14.533|90.279|31.75|34.6667|2|3|1.68|-1.5633|15.778|0.49|0.028|||14.208|0.95|35.99|46.64
new_0222_0158|KYMR|202012|302.339|296.202||20.686||203.287|110.617|92.67||283.888|-128.765||72.3304|-53.994|31.1473|5.053|62.4294||9.7147|||||2.3605|1.433|4.368|0.004|-29.9844||||-29.9844||44.4822|75|-0.29|5.175|44.4822||44.4822||2.6907|-0.29|-0.398||-29.9844|-45.592|34.034||12.785||-12.685|-12.685|0.097|62|62|2461.6944|219880.3||1049994|||35.0179|31.7835|-0.1425|21.6|-103.5088|-40.8102|-0.29|12.785|42.0182|81.1667|63|2|5|-1.27|-0.514|20.392|0.497|0.027|||14.252|0.95|61.95|47.98
new_0222_0158|KYMR|202103|340.791|333.537||20.502||189.305|110.137|79.168||275.247|-141.84||28.6054|-29.5481|20.2949|3.0362|29.8561||6.3362|||||4.8232|1.734|8.348|0.004|-19.934||||-27.016||44.6496|92|-0.29|5.909|44.8794||44.8794||3.0441|-0.29|||-27.016|-47.735|49.308||18.702||-13.075|-13.075|0.094|38.86|38.86|1410.4765|507145.2||2164621|||22.1443|20.099|-0.1975|19.052|-46.8354|-1.8371|-0.29|18.702|90.3333|76.8333|76.8|2|5|-0.91|-1.7575|25.962|0.485|0.024|||14.328|0.984|45.55|48.09
new_0222_0158|KYMR|202106|364.806|359.107||21.766||176.282|108.685|67.597||258.104|-166.5||28.4988|-31.4914|34.2965|4.2342|29.1018||8.5175||||-8.9462|5.1997|0.904|8.177|0.005|-24.0163|||1.4147|-24.0163||45.0942|112|-0.55|8.029|45.3277||45.3277||3.3124|-0.55|||-24.0163|-58.406|64.539||18.519||-24.66|-24.66|0.07|48.5|48.5|1839.2864|473162.5333|94.7962|2356885|||27.9137|25.3355|-0.2473|18.8138|-122.4379|-1.567|-0.55|18.519|84.0217|77.705|75.4286|1.75|7|-0.9676|-1.4024|35.22|0.552|0.028|||16.024|1.187|60.18|62.14
new_0222_0158|KYMR|202109|543.731|536.386||21.724||159.318|94.493|64.825||483.135|-195.082||35.1771|-31.3211|-21.8599|3.8515|38.6093||6.2318||||-8.0886|3.2102|1.573|5.033|0.005|-24.7646||8|1.6171|-24.7646||50.7148|136|-0.56|10.667|51.2566||51.2566||5.6931|-0.56|-243.135||-24.7646|-79.002|70.342||20.336||-28.582|-28.582|0.055|58.74|58.74|2474.4267|380982.5333|81.8013|1645458|||38.2293|34.6983|-0.3683|19.6115|-52.0417|3.6944|-0.56|20.336|84.656|81.4261|77.3333|1.6|9|-1.5713|-2.1787|38.306|0.671|0.07|||15.943|1.209|58.88|55.52
new_0222_0158|KYMR|202112|||||||||||||38.7561||-24.0839||41.7314||6.7529|||||3.8527||||||6|0.7801||||||||||||||||||||||||63.49|63.49|2726.181|323057.9333|2.4032|1979808|||37.5987|54.2656|-0.568|21.3131|||||83.7096|60.1221|78.4|1.5454|10|-1.9948|-2.5724||||||||42|38.8
new_0222_0158|KYMR|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.647|20.7179||||||||||||||||||||
new_0222_0158|KYMR|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.7877|16.8442||||||||||||||||||||
new_0222_0158|KYMR|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.7287|20.9023||||||||||||||||||||
new_0222_0158|KYMR|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.8319|17.4636||||||||||||||||||||